Predicting outcomes in hyperthyroid cats treated with radioiodine

被引:6
|
作者
Peterson, Mark E. [1 ,2 ]
Rishniw, Mark [2 ,3 ]
机构
[1] Anim Endocrine Clin, 220 Manhattan Ave, New York, NY 10025 USA
[2] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA
[3] Vet Informat Network, Davis, CA USA
关键词
I-131; feline; hypothyroidism; radioactive iodine; thyroid gland; treatment failure; THYROID-STIMULATING HORMONE; TOXIC NODULAR GOITER; RADIOACTIVE IODINE; LOGISTIC-REGRESSION; FELINE HYPERTHYROIDISM; PROGNOSTIC-FACTORS; THERAPY; HYPOTHYROIDISM; PERTECHNETATE; I-131;
D O I
10.1111/jvim.16319
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background Radioiodine (I-131) is the treatment of choice for cats with hyperthyroidism. After I-131, however, euthyroidism is not always achieved, with 5% to 10% of cats remaining persistently hyperthyroid and 20% to 50% developing iatrogenic hypothyroidism. Objectives To identify pretreatment factors that may help predict persistent hyperthyroidism and iatrogenic hypothyroidism after treatment of cats using a novel I-131 dosing algorithm. Animals One thousand and four hundred hyperthyroid cats treated with I-131. Methods Prospective, before-and-after study. Pretreatment predictors (clinical, laboratory, scintigraphic, I-131 dose, I-131 uptake measurements) of treatment failure or iatrogenic hypothyroidism were identified by multivariable logistic regression analysis. Results Cats that developed iatrogenic hypothyroidism were more likely to be older (odds ratio [OR] = 1.10; 95% confidence interval [CI], 1.04-1.17; P = .001), female (OR = 2.04; 95% CI, 1.54-2.70; P < .001), have detectable serum thyroid-stimulating hormone (TSH) concentrations (OR = 4.19; 95% CI, 2.0-8.81; P < .001), have bilateral thyroid nodules (OR = 1.57; 95% CI, 1.19-2.08; P < .001), have homogeneous, bilateral distribution of Tc-99m-pertechnetate uptake (OR = 2.93; 95% CI, 2.05-4.19; P < .001), have milder severity score (OR = 0.62; 95% CI, 0.49-0.79; P < .001), and have higher I-131 uptake (OR = 2.40; 95% CI, 1.75-3.28; P < .001). In contrast, cats remaining persistently hyperthyroid were more likely to be younger (OR = 0.81; 95% CI, 0.72-0.92; P < .001), have higher severity score (OR = 1.87; 95% CI, 1.51-2.31; P < .001), and have lower I-131 uptake (OR = 3.50; 95% CI, 1.8-6.80; P < .001). Conclusions and Clinical Importance Age, sex, serum TSH concentration, bilateral and homogeneous Tc-99m-pertechnetate uptake on scintigraphy, severity score, and percent I-131 uptake are all factors that might help predict outcome of I-131 treatment in hyperthyroid cats. Cats with persistent hyperthyroidism had many predictive factors that directly contrasted those of cats that developed I-131-induced hypothyroidism.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 50 条
  • [41] A novel method of continuous cage-side monitoring of hyperthyroid cats treated with radio-iodine
    Roberts, E.
    Gray, J. M.
    Gunn, E.
    Ramsey, I. K.
    VETERINARY RECORD, 2015, 177 (01) : 14
  • [42] Duration of T4 Suppression in Hyperthyroid Cats Treated Once and Twice Daily with Transdermal Methimazole
    Boretti, F. S.
    Sieber-Ruckstuhl, N. S.
    Schaefer, S.
    Baumgartner, C.
    Riond, B.
    Hofmann-Lehmann, R.
    Reusch, C. E.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2013, 27 (02) : 377 - 381
  • [43] Hyperthyroidism in cats Part II: scintigraphic diagnosis and radioiodine treatment
    Volckaert, V.
    Vandermeulen, E.
    Daminet, S.
    Saunders, J. H.
    Peremans, K.
    VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, 2016, 85 (05): : 265 - 273
  • [44] Leptin and ghrelin concentration in hyperthyroid cats before and after radioactive iodine therapy compared to euthyroid control cats
    Marsilio, Sina
    Glanemann, Barbara
    Martin, Lucile
    Szladovits, Balazs
    Neiger, Reto
    TIERAERZTLICHE PRAXIS AUSGABE KLEINTIERE HEIMTIERE, 2017, 45 (02): : 95 - 101
  • [45] Radioiodine therapy increases the risk of cerebrovascular events in hyperthyroid and euthyroid patients
    la Cour, Jeppe Lerche
    Jensen, Lars Thorbjoern
    Vej-Hansen, Anders
    Nygaard, Birte
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (06) : 771 - 778
  • [46] Study of cytogenetic toxicity of low-dose radioiodine therapy in hyperthyroid patients using a micronuclei assay
    Parida, Girish K.
    Bal, Chandrasekhar
    Dada, Rima
    Tripathi, Madhavi
    Dwivedi, Sadanand
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (08) : 800 - 804
  • [47] The influence of thiamazole, lithium carbonate, or prednisone administration on the efficacy of radioiodine treatment (131I) in hyperthyroid patients
    Oszukowska, Lidia
    Knapska-Kucharska, Malgorzata
    Makarewicz, Jacek
    Lewinski, Andrzej
    ENDOKRYNOLOGIA POLSKA, 2010, 61 (01) : 56 - 61
  • [48] Effects of drugs on the efficacy of radioiodine (131I) therapy in hyperthyroid patients
    Oszukowska, Lidia
    Knapska-Kucharska, Malgorzata
    Lewinski, Andrzej
    ARCHIVES OF MEDICAL SCIENCE, 2010, 6 (01) : 4 - 10
  • [49] Scintigraphic findings in 120 hyperthyroid cats
    Harvey, Andrea M.
    Hibbert, Angie
    Barrett, Esther L.
    Day, Michael J.
    Quiggin, Anna V.
    Brannan, Rachael M.
    Caney, Sarah M. A.
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2009, 11 (02) : 96 - 106
  • [50] Effect of Presence of Uni- or Bilateral Thyroid Adenoma on Recovery of Pituitary-Thyroid Axis and Creatinine Concentration in Radioiodine-Treated Cats
    Menzel, Anna Paulina
    Lin, Joanna
    Guessow, Arne
    Patzelt, Ve
    Bauer, Natali
    Hazuchova, Katarina
    ANIMALS, 2024, 14 (18):